Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Dorte Remmer Schmidt"'
Autor:
Eskild Petersen, Steen Honoré Hansen, Ole Andersen, Kim Dalhoff, Birthe Høgh, Dorte Remmer Schmidt
Publikováno v:
Schmidt, D R, Høgh, B, Andersen, O, Honoré, S H, Dalhoff, K & Petersen, E 2006, ' Treatment of infants with congenital toxoplasmosis: Tolerability and plasma concentrations of sulfadiazine and pyrimethamine ', Eur J Pediatr, vol. 165, pp. 19-25 .
The aim was to study the tolerability and plasma concentrations of pyrimethamine and sulfadiazine in children treated for congenital toxoplasmosis. Infants were diagnosed through the Danish Toxoplasma Neonatal Screening Programme, based on detection
Publikováno v:
Journal of Clinical Microbiology. 43:711-715
Differentiation between the specific immunoglobulin G (IgG) response to Toxoplasma gondii by a mother and her newborn child is helpful in the diagnosis of congenital infection with T. gondii in newborns without T. gondii -specific IgM and/or IgA anti
Autor:
Eskild Petersen, Dorte Remmer Schmidt
Publikováno v:
Expert Review of Anti-infective Therapy. 1:175-182
Pre- and neonatal screening for congenital toxoplasmosis rests upon the assumption that treatment is beneficial on either acute symptoms or in preventing later reactivation. Postpartum treatment of congenital toxoplasmosis with sulfadiazine and pyrim
Aims: To describe the outcome of four years’ nationwide neonatal screening for congenital toxoplasmosis in liveborn newborns. Methods: Congenital toxoplasmosis was diagnosed if specific Toxoplasma gondii IgM antibodies were detected in eluate from
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9961a6e12842ff350c2c9389ab7c3b57
https://europepmc.org/articles/PMC2083029/
https://europepmc.org/articles/PMC2083029/
Autor:
Ida Skovgaard Christiansen, Dorte Remmer Schmidt, Steen Honoré Hansen, Jane Krogh Johannessen, Eskild Petersen
Publikováno v:
Journal of pharmaceutical and biomedical analysis. 36(5)
A method for the simultaneous determination of pyrimethamine, sulfadiazine and its metabolite N -acetyl-sulfadiazine in small plasma samples from neonates in treatment for congenital toxoplasmosis has been developed. In this method only 25 μl of pla